A Trial Comparing Split-Dose Miralax With Amitiza Pretreatment Versus Dulcolax Pretreatment Versus Golytely for Bowel Cleansing Prior to Colonoscopy

Completed · Phase 4

Conditions studied: Colonoscopy

In brief

Miralax (PEG 3350) has been shown to be a safe and uncomplicated bowel preparation prior to colonoscopy in pediatric populations. This study seeks to confirm the efficacy of this bowel cleansing regimen in adults and to determine the benefit of adding a pretreatment medication to this bowel preparation. The tolerability of Miralax will hopefully improve patient satisfaction with colonoscopy and decrease their reluctance to be screened because of the uncomfortable taste and side effects of bowel preparation regimens.

Key facts

Study ID

NCT00953017

Run by

Brooke Army Medical Center

People needed

425

Starts

2009-07-01

Expected to finish

2010-05-01

Last updated by the study team

2012-11-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• adult patients referred to our clinic for average or increased risk screening for colorectal cancer

You may not qualify if…

• elevated serum creatinine (Men >1.4mg/dL, Women >1.3mg/dL)
• previous diagnosis of congestive heart failure
• history of bowel obstruction
• history of solid organ transplant
• current pregnancy
• lactating mother
• participants allergic to either polyethylene glycol (Miralax), lubiprostone (Amitiza), or bisacodyl (Dulcolax)

Where it is running

• Brooke Army Medical Center — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.